Concepedia

Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma

Rahul Banerjee, Jeffrey Marsal, Chiung‐Yu Huang, Mimi Lo, Swetha Kambhampati Thiruvengadam, Vanessa E. Kennedy, Shagun Arora, Jeffrey L. Wolf, Thomas Martin, Sandy W. Wong,

Transplantation and Cellular Therapy · 2021 · 48 citations · 27 references

DOI

Concepts

References

27

Current concepts in the diagnosis and management of cytokine release syndrome

Daniel W. Lee, Rebecca Gardner, David Porter et al. · Blood · 2014 · 2.8K citations

, , +14

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva et al. · Journal of Clinical Oncology · 2015 · 2.2K citations · Full text

, , +16

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 882 citations · Full text

, , +16

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

Joshua A. Hill, Daniel Li, Kevin A. Hay et al. · Blood · 2017 · 566 citations · Full text

, , +15

Early and late hematologic toxicity following CD19 CAR-T cells

Shalev Fried, Abraham Avigdor, Bella Bielorai et al. · Bone Marrow Transplantation · 2019 · 401 citations

, , +14